1
|
Santos Bravo M, Plault N, Sánchez-Palomino S, Rodríguez C, Navarro Gabriel M, Mosquera MM, Fernández Avilés F, Suarez-Lledó M, Rovira M, Bodro M, Moreno A, Linares L, Cofan F, Berengua C, Esteva C, Cordero E, Martin-Davila P, Aranzamendi M, Pérez Jiménez AB, Vidal E, Fernández Sabé N, Len O, Hantz S, Alain S, Marcos MÁ. Genotypic and phenotypic study of antiviral resistance mutations in refractory cytomegalovirus infection. J Infect Dis 2022; 226:1528-1536. [PMID: 35993155 DOI: 10.1093/infdis/jiac349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2022] [Accepted: 08/18/2022] [Indexed: 11/14/2022] Open
Abstract
This study describes the genotypic and phenotypic characterisation of novel human cytomegalovirus (HCMV) genetic variants of a cohort of 94 clinically-resistant HCMV patients. Antiviral-resistant mutations were detected in the UL97, UL54 and UL56 target genes of 25/94 (26.6%) patients. The genotype-phenotype correlation study resolved the status of 5 uncharacterised UL54 DNA polymerase (G441S, A543V, F460S, R512C, A928T) and 2 UL56 terminase (F345L, P800L) mutations found in clinical isolates. A928T conferred high triple-resistance to ganciclovir, foscarnet and cidofovir, and A543V had 10-fold reduced susceptibility to cidofovir. Viral growth assays showed G441S, A543V, F345L and P800L impaired viral growth capacities compared with wild-type AD169 HCMV. 3D modelling predicted A543V and A928T phenotypes but not R512C, reinforcing the need for individual characterisation of mutations by recombinant phenotyping. Extending mutation databases is crucial to optimize treatments and to improve the assessment of patients with resistant/refractory HCMV infection.
Collapse
Affiliation(s)
- Marta Santos Bravo
- Microbiology Department, Hospital Clinic of Barcelona, University of Barcelona. Institute for Global Health (ISGlobal), Barcelona, Spain
| | - Nicolas Plault
- National Reference Center for Herpesviruses, Microbiology Department, CHU Limoges, Limoges, France.,UMR Inserm 1092, University of Limoges, Limoges, France
| | - Sonsoles Sánchez-Palomino
- AIDS Research Group, Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic I Provincial de Barcelona, University of Barcelona, Barcelona, Spain
| | - Cristina Rodríguez
- Microbiology Department, Hospital Clinic of Barcelona, University of Barcelona. Institute for Global Health (ISGlobal), Barcelona, Spain
| | - Mireia Navarro Gabriel
- Microbiology Department, Hospital Clinic of Barcelona, University of Barcelona. Institute for Global Health (ISGlobal), Barcelona, Spain
| | - María Mar Mosquera
- Microbiology Department, Hospital Clinic of Barcelona, University of Barcelona. Institute for Global Health (ISGlobal), Barcelona, Spain
| | - Francesc Fernández Avilés
- Bone Marrow Transplant Unit, Hematology Department, Clinical Institute of Hematological and Oncological Diseases (ICMHO) Hospital Clinic of Barcelona, , Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Josep Carreras Leukaemia Research Institute, Barcelona, Spain
| | - María Suarez-Lledó
- Bone Marrow Transplant Unit, Hematology Department, Clinical Institute of Hematological and Oncological Diseases (ICMHO) Hospital Clinic of Barcelona, , Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Josep Carreras Leukaemia Research Institute, Barcelona, Spain
| | - Montserrat Rovira
- Bone Marrow Transplant Unit, Hematology Department, Clinical Institute of Hematological and Oncological Diseases (ICMHO) Hospital Clinic of Barcelona, , Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Josep Carreras Leukaemia Research Institute, Barcelona, Spain
| | - Marta Bodro
- Infectious Diseases Department, Hospital Clinic of Barcelona, Barcelona, Spain
| | - Asunción Moreno
- Infectious Diseases Department, Hospital Clinic of Barcelona, Barcelona, Spain
| | - Laura Linares
- Infectious Diseases Department, Hospital Clinic of Barcelona, Barcelona, Spain
| | - Frederic Cofan
- Renal Transplantation Unit, Department of Nephrology. Hospital Clinic of Barcelona, Barcelona, Spain
| | - Carla Berengua
- Microbiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | - Cristina Esteva
- Molecular Microbiology Unit, Hospital Universitari Sant Joan de Déu, Barcelona, Spain. Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Universitat de Barcelona. Centre of Biomedical Research for Epidemiology and Public Health (CIBERESP), Barcelona, Spain
| | - Elisa Cordero
- Clinical Unit of Infectious Diseases, Microbiology, and Preventive Medicine. Viral and Infectious Diseases in Immunodeficient Group. Institute of Biomedicine of Seville (IBiS). Virgen del Rocio University Hospital. University of Seville. Seville, Spain
| | | | - Maitane Aranzamendi
- Microbiology Department. Hospital Universitario de Cruces, Donostia, Gipuzkoa, Spain
| | - Ana Belén Pérez Jiménez
- Microbiology Unit, Hospital Universitario Reina Sofía, Intituto Maimonides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. Centre of Biomedical Research for Infectious Diseases (CIBERINFEC), Intitute of Carlos III, Madrid, Spain
| | - Elisa Vidal
- Microbiology Unit, Hospital Universitario Reina Sofía, Intituto Maimonides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. Centre of Biomedical Research for Infectious Diseases (CIBERINFEC), Intitute of Carlos III, Madrid, Spain
| | - Nuria Fernández Sabé
- Department of Infectious Diseases, Bellvitge University Hospital, Insitut D'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain
| | - Oscar Len
- Department of Infectious Diseases, Hospital Universitari Vall d'Hebrón, Universitat Autónoma de Barcelona, Barcelona, Spain
| | - Sebastien Hantz
- National Reference Center for Herpesviruses, Microbiology Department, CHU Limoges, Limoges, France.,UMR Inserm 1092, University of Limoges, Limoges, France
| | - Sophie Alain
- National Reference Center for Herpesviruses, Microbiology Department, CHU Limoges, Limoges, France.,UMR Inserm 1092, University of Limoges, Limoges, France
| | - María Ángeles Marcos
- Microbiology Department, Hospital Clinic of Barcelona, University of Barcelona. Institute for Global Health (ISGlobal), Barcelona, Spain
| | | |
Collapse
|
2
|
Gabriel MN, Calloway CD, Reynolds RL, Andelinović S, Primorac D. Population variation of human mitochondrial DNA hypervariable regions I and II in 105 Croatian individuals demonstrated by immobilized sequence-specific oligonucleotide probe analysis. Croat Med J 2001; 42:328-35. [PMID: 11387647] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/20/2023] Open
Abstract
AIM To detect sequence variation in 105 Croatian individuals by the use of duplex polymerase chain reaction amplification of full-length hypervariable region I and II (HVI/HVII) products and subsequent hybridization to a linear array of 27 immobilized sequence-specific oligonucleotide (SSO) probes, which targets six regions within HVI and HVII, and two additional sites, 189 and 16093. METHODS Chelex-extracted bloodstains were used for amplification of HV regions. In all cases, a single robust amplification was sufficient for immobilized SSO probe typing and subsequent direct sequence analysis for both HVI and HVII. This method, suitable for a range of forensic samples (including shaft portions of single hairs), was also applied to the analysis of 18 skeletal elements recovered from a mass grave. Using a panel of immobilized SSO probes, we have developed a rapid screening approach to mitochondrial DNA (mtDNA) haplotyping before direct sequence analysis. RESULTS We established a reference sequence database of mtDNA haplotypes for 105 randomly selected Croatian individuals. Fifty different mitotypes were observed (33 unique). The most frequent mitotypes occurred 18 times or approximately 17.1% [111111 189 (A) 16093 (T)] and 11 times or approximately 10.5% [131111 189 (A) 16093 (T)]; all other mitotypes occurred 5% or less. The corresponding genetic diversity value for this database was approximately 0.952. The usefulness of establishing an mtDNA reference database with immobilized SSO probe testing has been demonstrated by determining the strength of a match comparison obtained for one skeletal element and a corresponding maternal reference from 18 specimens recovered from a mass grave. CONCLUSION The sequence variation detected by the panel of immobilized SSO probes is sufficiently diverse to be used for identification of human skeletal remains from mass graves. The immobilized SSO typing strip targets polymorphic regions within HVI and HVII and is a useful identification tool for mass grave and mass disaster analysis, as well as for criminal casework testing.
Collapse
Affiliation(s)
- M N Gabriel
- Roche Molecular Systems, Department of Human Genetics, Alameda, CA, USA.
| | | | | | | | | |
Collapse
|
3
|
Gabriel MN, Huffine EF, Ryan JH, Holland MM, Parsons TJ. Improved MtDNA sequence analysis of forensic remains using a "mini-primer set" amplification strategy. J Forensic Sci 2001; 46:247-53. [PMID: 11305426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
Mitochondrial DNA (mtDNA) analysis of highly degraded skeletal remains is often used for forensic identification due largely to the high genome copy number per cell. Literature from the "ancient DNA" field has shown that highly degraded samples contain populations of intact DNA molecules that are severely restricted in size (1-4). Hand et al. have demonstrated the targeting and preferential amplification of authentic human DNA sequences with small amplicon products of 150 bp or less (1,2). Given this understanding of ancient DNA preservation and amplification, we report an improved approach to forensic mtDNA analysis of hypervariable regions 1 and 2 (HV1/HV2) in highly degraded specimens. This "mini-primer set" (MPS) amplification strategy consists of four overlapping products that span each of the HV regions and range from 126 to 170 bp, with an average size of 141 bp. For this study, 11 extracts representing a range of sample quality were prepared from nonprobative forensic specimens. We demonstrate a significant increase in MPS amplification success when compared to testing methods using approximately 250 bp amplicons. Further, 16 of 17 independent amplifications previously "unreported" due to mixed sequences provided potentially reportable sequence data from a single, authentic template with MPS testing.
Collapse
Affiliation(s)
- M N Gabriel
- MtDNA Section, The Armed Forces DNA Identification Laboratory, Rockville, Maryland 20850, USA
| | | | | | | | | |
Collapse
|
4
|
Abstract
A subpopulation of stably infected CD4+ cells capable of producing virus upon stimulation has been identified in human immunodeficiency virus (HIV)-positive individuals (T.-W. Chun, D. Finzi, J. Margolick, K. Chadwick, D. Schwartz, and R. F. Siliciano, Nat. Med. 1:1284-1290, 1995). Few host factors that directly limit HIV-1 transcription and could support this state of nonproductive HIV-1 infection have been described. YY1, a widely distributed human transcription factor, is known to inhibit HIV-1 long terminal repeat (LTR) transcription and virus production. LSF (also known as LBP-1, UBP, and CP-2) has been shown to repress LTR transcription in vitro, but transient expression of LSF has no effect on LTR activity in vivo. We report that both YY1 and LSF participate in the formation of a complex that recognizes the initiation region of the HIV-1 LTR. Further, we have found that these factors cooperate in the repression of LTR expression and viral replication. This cooperative function may account for the divergent effects of LSF previously observed in vitro and in vivo. Thus, the cooperation of two general cellular transcription factors may allow for the selective downregulation of HIV transcription. Through this mechanism of gene regulation, YY1 and LSF could contribute to the establishment and maintenance of a population of cells stably but nonproductively infected with HIV-1.
Collapse
Affiliation(s)
- F Romerio
- Institute of Human Virology, Medical Biotechnology Center, University of Maryland Biotechnology Institute, Baltimore 21201, USA
| | | | | |
Collapse
|